• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

    12.19 -0.55 (-4.32%)
    Official Closing Price Updated: 7:00 PM EDT, Oct 29, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

    < Previous 1 2
    ...
    5 6 7 8 9 10 11 12 13
    ...
    17 18 Next >
    Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries
    Evogene employs an artificial intelligence platform for decoding plant phenotypes and microbial genomes. Consider its' research agenda, applications, and at-the-market products. The set-up may present... 
    Via Talk Markets
    Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Investor Notice: Investigation over Potential Wrongdoing
    San Diego, CA -- (SBWIRE) -- 04/25/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Ginkgo Bioworks Holdings, Inc.. 
    Via SBWire
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
    The growth-focused money manager is making moves. 
    Via The Motley Fool
    Cathie Wood Bets Big On Roblox With $19.5M Purchase — Also Loads Up On This Biotech Stock
     
    Via Benzinga
    5 Penny Stocks With Explosive 5X Potential
    Penny stocks are inherently risky, but investing in low-priced companies with wide "moats" can shift the odds in investors' favor. 
    Via InvestorPlace
    Earnings Scheduled For March 1, 2023
    Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
    Via Benzinga
    Ginkgo Bioworks Holdings's Earnings: A Preview
     
    Via Benzinga
    Is It Too Early to Invest in Ginkgo Bioworks?
    Ginkgo is on track to easily beat its guidance for 2022. But what about its bottom line? 
    Via The Motley Fool
    3 Growth Stocks to Buy for 100% Returns
    These three growth stocks to buy could provide triple-digit percentage returns for investors in the near to mid term. 
    Via InvestorPlace
    Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global
     
    Via Benzinga
    This Growth Stock Is Down 63% in 1 Year. Here's Why You Should Buy the Dip and Hold It for 5 Years
    The bear market hasn't been kind, but the future could be a lot better. 
    Via The Motley Fool
    Bragar Eagel & Squire is Investigating Certain Officers and Directors of C3.ai, Ginkgo Bioworks, and Polished on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    GINKGO BIOWORKS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Ginkgo Bioworks Holdings, Inc. - DNA
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Luminar Technologies, EHang Holdings And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    U.S. stock futures traded slightly lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
    Via Benzinga
    Evogene Offers An Excellent Risk/Reward Ratio
    We think the company’s main CPB computational engine has the potential to be an extraordinary value creation engine. Investors only need one of the company's subsidiaries to succeed, to de-risk their... 
    Via Talk Markets
    7 Penny Stocks With Massive Growth Potential
    If you laugh at red ink, these tempting ideas just might be for you. 
    Via InvestorPlace
    Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
    The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the... 
    Via Benzinga
    Buy the Dip: 2 Exceptional Growth Stocks to Grab Before the Next Bull Market
    Now's the time to load up on stocks that got dented in the bear market. 
    Via The Motley Fool
    GINKGO BIOWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Ginkgo Bioworks Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Cronos Group Reports 2022 Fourth Quarter and Full-Year Results
    From Cronos Group Inc.
    Via GlobeNewswire
    To The Moon: Intuitive Machines Blasts 10x in a Week...But Why?
    The modern version of the Cold War Space Race has implications for scientific discovery and satellite communications. Intuitive Machines is in the thick of it. 
    Via MarketBeat
    This Biotech Is Already Using AI, but Is the Growth Stock a Buy?
    Few biotechs can claim to be using AI in as central of a role as Ginkgo Bioworks. 
    Via The Motley Fool
    Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Ginkgo Bioworks Holdings Inc. (DNA) Investigation
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    2 Bruised Growth Stocks to Buy While They're Cheap
    Both are on the verge of fast growth, and they haven't had any major setbacks yet. 
    Via The Motley Fool
    The Next Big Disruptors? 3 Biotech Stocks Making Headlines.
    Biotech stocks were hard-hit in 2022, but these disruptive names in the field of synthetic biology can be big winners in 2023. 
    Via InvestorPlace
    3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
    These stocks are risky. But they just might deliver huge gains if analysts are right. 
    Via The Motley Fool
    Investigation Announced for Investors Who Lost Money with NYSE: DNA Shares over Possible Violations of Securities Laws by Ginkgo Bioworks Holdings, Inc.
    San Diego, CA -- (SBWIRE) -- 02/01/2023 -- An investigation was announced for investors of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) shares over potential securities laws violations by Ginkgo Bioworks... 
    Via SBWire
    GINKGO BIOWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Ginkgo Bioworks Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    3 Penny Stocks That Could Rise 500% in 2023
    Tilt the odds in your favor in 2023 with some of these high-potential penny stocks. The risks are high, but so are the rewards. 
    Via InvestorPlace
    Stocks That Hit 52-Week Lows On Wednesday
      On Wednesday, 35 companies reached new 52-week lows. 
    Via Benzinga
    < Previous 1 2
    ...
    5 6 7 8 9 10 11 12 13
    ...
    17 18 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.